Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleMedical Practice

Ecstasy (3,4-Methylenedioxymethamphetamine): History, Neurochemistry, and Toxicology

James A. Rochester and Jeffrey T. Kirchner
The Journal of the American Board of Family Practice March 1999, 12 (2) 137-142; DOI: https://doi.org/10.3122/jabfm.12.2.137
James A. Rochester
From the Department of Family and Community Medicine (JAR, JTK), Lancaster General Hospital, Lancaster, Pa. Address reprint requests to Jeffrey T. Kirchner, DO, Department of Family and Community Medicine, Lancaster General Hospital, Lancaster, PA 17604
MD, USAF, MC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey T. Kirchner
From the Department of Family and Community Medicine (JAR, JTK), Lancaster General Hospital, Lancaster, Pa. Address reprint requests to Jeffrey T. Kirchner, DO, Department of Family and Community Medicine, Lancaster General Hospital, Lancaster, PA 17604
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Background: 3,4-Methylenedioxymethamphetamine (MDMA; ecstasy), a compound chemically related to stimulant and hallucinogenic drugs, has been found to induce a state of euphoria and increased self-awareness. MDMA has been increasingly used for recreational purposes, especially among college students and other young adults, and has been associated with multiple toxic effects.

Methods: Using MEDLINE, the medical literature was searched from 1986 using the key words “ecstasy,” “MDMA,” and “designer drugs.” Articles dating before 1986 were accessed from cross-reference of the more recent articles. A case report is described.

Results: MDMA was developed in 1912 as an appetite suppressant but never became commercially successful. It resurfaced in the 1950s as a psychotherapeutic agent. In 1985 MDMA was classified as a schedule 1 drug by the Food and Drug Administration after reports of neurotoxicity in laboratory animals. It again resurfaced in the mid 1980s as a recreational drug used primarily among college students and other young adults. There are a number of case reports describing toxic effects from MDMA, including hyperthermia, rhabdomyolysis, coagulopathy, and acute renal failure. Little information is available regarding acute management or treatment of toxic ingestions.

Conclusions: MDMA ingestion has been associated with severe toxic effects. Although the literature describes numerous cases of toxic ingestion, there are no published recommendations or suggestions to guide physicians in the evaluation and treatment of such cases. By reviewing the history, neurochemistry, and toxicology of MDMA, as well as providing some guidance regarding management of toxic ingestion, we can arm the provider with valuable information for use in the acute setting. In addition, this information will assist providers in counseling young adults regarding the possible consequences of using this substance.

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Practice: 12 (2)
The Journal of the American Board of Family Practice
Vol. 12, Issue 2
1 Mar 1999
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
  • Back Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ecstasy (3,4-Methylenedioxymethamphetamine): History, Neurochemistry, and Toxicology
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Ecstasy (3,4-Methylenedioxymethamphetamine): History, Neurochemistry, and Toxicology
James A. Rochester, Jeffrey T. Kirchner
The Journal of the American Board of Family Practice Mar 1999, 12 (2) 137-142; DOI: 10.3122/jabfm.12.2.137

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Ecstasy (3,4-Methylenedioxymethamphetamine): History, Neurochemistry, and Toxicology
James A. Rochester, Jeffrey T. Kirchner
The Journal of the American Board of Family Practice Mar 1999, 12 (2) 137-142; DOI: 10.3122/jabfm.12.2.137
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Raves: a review of the culture, the drugs and the prevention of harm
  • Google Scholar

More in this TOC Section

  • Nontraumatic Rhabdomyolysis with Long-Term Alcohol Intoxication
  • Cough as the Presenting Symptom of Pancreatic Adenocarcinoma
  • Vasa Previa Diagnosis and Management
Show more Medical Practice

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire